These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 27884222)

  • 41. Overview of endocrine systems in primary hypertension.
    Carey RM
    Endocrinol Metab Clin North Am; 2011 Jun; 40(2):265-77, vii. PubMed ID: 21565666
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The mitochondrial component of intracrine action.
    Re RN; Cook JL
    Am J Physiol Heart Circ Physiol; 2010 Sep; 299(3):H577-83. PubMed ID: 20622110
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cardio-renal syndrome type 1: epidemiology, pathophysiology, and treatment.
    Ismail Y; Kasmikha Z; Green HL; McCullough PA
    Semin Nephrol; 2012 Jan; 32(1):18-25. PubMed ID: 22365158
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects?
    Kujal P; Chábová VČ; Vernerová Z; Walkowska A; Kompanowska-Jezierska E; Sadowski J; Vaňourková Z; Husková Z; Opočenský M; Skaroupková P; Schejbalová S; Kramer HJ; Rakušan D; Malý J; Netuka I; Vaněčková I; Kopkan L; Cervenka L
    Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1159-69. PubMed ID: 20880190
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Central mineralocorticoid receptors and the role of angiotensin II and glutamate in the paraventricular nucleus of rats with angiotensin II-induced hypertension.
    Gabor A; Leenen FH
    Hypertension; 2013 May; 61(5):1083-90. PubMed ID: 23509081
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathophysiology of cardiorenal syndrome in decompensated heart failure: role of lung-right heart-kidney interaction.
    Guazzi M; Gatto P; Giusti G; Pizzamiglio F; Previtali I; Vignati C; Arena R
    Int J Cardiol; 2013 Nov; 169(6):379-84. PubMed ID: 24182905
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic kidney disease.
    Bertocchio JP; Warnock DG; Jaisser F
    Kidney Int; 2011 May; 79(10):1051-60. PubMed ID: 21412221
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [PATHOPHYSIOLOGY OF CARDIORENAL SYNDROME].
    Thervet É
    Rev Prat; 2016 Jun; 66(6):611-5. PubMed ID: 27538312
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dual blockade of the renin-angiotensin-aldosterone system: beyond the ACE inhibitor and angiotensin-II receptor blocker combination.
    Bomback AS; Toto R
    Am J Hypertens; 2009 Oct; 22(10):1032-40. PubMed ID: 19661925
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of the Vasoconstriction-Inhibiting Factor (VIF), a Potent Endogenous Cofactor of Angiotensin II Acting on the Angiotensin II Type 2 Receptor.
    Salem S; Jankowski V; Asare Y; Liehn E; Welker P; Raya-Bermudez A; Pineda-Martos C; Rodriguez M; Muñoz-Castañeda JR; Bruck H; Marx N; Machado FB; Staudt M; Heinze G; Zidek W; Jankowski J
    Circulation; 2015 Apr; 131(16):1426-34. PubMed ID: 25810338
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Pathogenic Mechanism Potentially Operative in Multiple Progressive Diseases and Its Therapeutic Implications.
    Re RN
    J Clin Pharmacol; 2017 Dec; 57(12):1507-1518. PubMed ID: 28884862
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Chronic kidney disease and atrial fibrillation as components of the cardiorenal continuum].
    Mukhin NA; Glybochko PV; Svistunov AA; Fomin VV; Kiyakbaev GG
    Ter Arkh; 2016; 88(6):4-8. PubMed ID: 27489904
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of cardiorenal metabolic syndrome in diabetes mellitus: a phytotherapeutic perspective.
    Song MK; Davies NM; Roufogalis BD; Huang TH
    J Diabetes Res; 2014; 2014():313718. PubMed ID: 24818164
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Age-Related Macular Degeneration and Intracrine Biology: An Hypothesis.
    Re RN
    Ochsner J; 2016; 16(4):502-510. PubMed ID: 27999510
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Resistance to insulin and kidney disease in the cardiorenal metabolic syndrome; role for angiotensin II.
    Nistala R; Whaley-Connell A
    Mol Cell Endocrinol; 2013 Sep; 378(1-2):53-8. PubMed ID: 23416840
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Next Frontier: Biomarkers and Artificial Intelligence Predicting Cardiorenal Outcomes in Diabetic Kidney Disease.
    Braden GL; Landry DL
    Kidney360; 2022 Sep; 3(9):1480-1483. PubMed ID: 36245646
    [No Abstract]   [Full Text] [Related]  

  • 57. Nutrient-derived modification of mineral corticoid receptors is relevant to diabetic kidney disease progression.
    Kanasaki K
    Hypertens Res; 2023 Jan; 46(1):261-263. PubMed ID: 36380204
    [No Abstract]   [Full Text] [Related]  

  • 58. Altered Renal Vascular Responsiveness to Vasoactive Agents in Rats with Angiotensin II-Dependent Hypertension and Congestive Heart Failure.
    Vacková Š; Kikerlová S; Melenovsky V; Kolář F; Imig JD; Kompanowska-Jezierska E; Sadowski J; Červenka L
    Kidney Blood Press Res; 2019; 44(4):792-809. PubMed ID: 31430751
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of angiotensin-converting enzyme blockade, alone or combined with blockade of soluble epoxide hydrolase, on the course of congestive heart failure and occurrence of renal dysfunction in Ren-2 transgenic hypertensive rats with aorto-caval fistula.
    Kala P; Sedláková L; Škaroupková P; Kopkan L; Vaňourková Z; Táborský M; Nishiyama A; Hwang SH; Hammock BD; Sadowski J; Melenovský V; Imig JD; Červenka L
    Physiol Res; 2018 Jul; 67(3):401-415. PubMed ID: 29527914
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Reassessment of the Pathophysiology of Progressive Cardiorenal Disorders.
    Re RN
    Med Clin North Am; 2017 Jan; 101(1):103-115. PubMed ID: 27884222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.